|November 15th, 2017
|| Karim Dabbagh, Ph.D.
Chief Scientific Officer
|December 13th, 2017
|| Tim Sullivan, Ph.D.
Vice President, Business Development
|January 24th, 2018
|| Irving Weissman, M.D.
Director, Institute of Stem Cell Biology and Regenerative Medicine,
Director, Stanford Ludwig Center for Cancer Stem Cell Research and Medicine,
Professor of Pathology and Developmental Biology, Stanford University
Co-Founder and Board Member, Forty Seven Inc
|February 28th, 2018
|| Neil Kumar, Ph.D.
Chief Executive Officer and Founder
|March 21st, 2018
|| Hing Sham, Ph.D.
Senior Vice President, Research
Global Blood Therapeutics
|April 18th, 2018
|| Nathaniel David, Ph.D.
|May 23rd, 2018
|| Anne-Marie Duliege, M.D.
Executive Vice President and Chief Medical Officer